determine the miRNAs with the greatest contribution to this GBM cancer phenotypic state and utilize this miRNA signature to robustly distinguish between healthy and GBM cancer patients. In addition, the analysis characterizes degrees of patient variability, or the thermodynamic potentials of the disease for each patient. These patient-specific potentials in the cancer phenotypic state may provide an avenue for development of personalized diagnostics.
NSDNA: The Nervous System Disease NcRNAome Atlas
Contact wanglh211@163.com for inquiries and feedback